UBS Group’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-893,856
| Closed | -$25.6M | – | 7404 |
|
|
2018
Q4 | $25.6M | Sell |
893,856
-104,133
| -10% | -$2.98M | 0.01% | 711 |
|
|
2018
Q3 | $27.8M | Buy |
997,989
+15,673
| +2% | +$437K | 0.01% | 785 |
|
|
2018
Q2 | $27.4M | Buy |
982,316
+483,274
| +97% | +$13.5M | 0.01% | 764 |
|
|
2018
Q1 | $12.4M | Sell |
499,042
-202,409
| -29% | -$5.03M | 0.01% | 1194 |
|
|
2017
Q4 | $17M | Buy |
701,451
+209,495
| +43% | +$5.08M | 0.01% | 1005 |
|
|
2017
Q3 | $13.6M | Buy |
491,956
+470,693
| +2,214% | +$13M | 0.01% | 1072 |
|
|
2017
Q2 | $533K | Buy |
21,263
+493
| +2% | +$12.4K | ﹤0.01% | 3318 |
|
|
2017
Q1 | $557K | Buy |
20,770
+2,035
| +11% | +$54.6K | ﹤0.01% | 3208 |
|
|
2016
Q4 | $491K | Buy |
18,735
+270
| +1% | +$7.08K | ﹤0.01% | 3332 |
|
|
2016
Q3 | $461K | Sell |
18,465
-4,598
| -20% | -$115K | ﹤0.01% | 3198 |
|
|
2016
Q2 | $500K | Sell |
23,063
-10,128
| -31% | -$220K | ﹤0.01% | 3151 |
|
|
2016
Q1 | $498K | Sell |
33,191
-5,091
| -13% | -$76.4K | ﹤0.01% | 3127 |
|
|
2015
Q4 | $838K | Buy |
38,282
+24,425
| +176% | +$535K | ﹤0.01% | 2805 |
|
|
2015
Q3 | $219K | Sell |
13,857
-4,869
| -26% | -$77K | ﹤0.01% | 3645 |
|
|
2015
Q2 | $267K | Sell |
18,726
-4,519
| -19% | -$64.4K | ﹤0.01% | 3678 |
|
|
2015
Q1 | $402K | Sell |
23,245
-1,971
| -8% | -$34.1K | ﹤0.01% | 3365 |
|
|
2014
Q4 | $452K | Buy |
+25,216
| New | +$452K | ﹤0.01% | 3268 |
|